{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:57Z","timestamp":1791295617331,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.beha.2005.07.011","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T13:25:13Z","timestamp":1150377913000},"page":"617-633","source":"Crossref","is-referenced-by-count":75,"title":["Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: Pathogenetic mechanisms and prevention"],"prefix":"10.1016","volume":"19","author":[{"given":"Raffaele","family":"Landolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Celeste","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Novarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.07.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","article-title":"Bleeding and thrombosis in myeloproliferative disorders","volume":"64","author":"Schafer","year":"1984","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib2","first-page":"203","article-title":"Rocca B & Patrono C","volume":"20","author":"Landolfi","year":"1995","journal-title":"Bleeding and thrombosis in myeloproliferative disorders: mechanism and treatment. Crit Rev Oncol Ematol."},{"key":"10.1016\/j.beha.2005.07.011_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrage in polycythemia vera and essential thrombocythemia","volume":"128","author":"Elliott","year":"2004","journal-title":"Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib4","doi-asserted-by":"crossref","unstructured":"Gruppo Italiano Studio Policitemia. Polycytemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med. 1995;123:656-664.","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"10.1016\/j.beha.2005.07.011_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-102-4-466","article-title":"Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia","volume":"102","author":"Michiels","year":"1985","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.beha.2005.07.011_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2007-996106","article-title":"Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism-thesis","volume":"23","author":"Michiels","year":"1997","journal-title":"Rotterdam, 1981. Semin Thromb Haemost."},{"key":"10.1016\/j.beha.2005.07.011_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0038-1653752","article-title":"Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin","volume":"73","author":"Van Genderen","year":"1995","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.beha.2005.07.011_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin","volume":"97","author":"Van Genderen","year":"1997","journal-title":"Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib9","doi-asserted-by":"crossref","unstructured":"Kurzrock R & Cohen PR. Erythromelalgia: review of clinical characteristics and pathophysiology. Am J Med. 1991;91:416-422.","DOI":"10.1016\/0002-9343(91)90160-Y"},{"key":"10.1016\/j.beha.2005.07.011_bib10","unstructured":"Zucker S & Mielke CH. Classification of thrombocytosis based on platelet function test: correlation with hemorrhagic and thrombotic complications. J Lab Clin Med. 1972;80:385-394."},{"key":"10.1016\/j.beha.2005.07.011_bib11","first-page":"1107","article-title":"Mulder A & Van Vliet HH","volume":"43","author":"Michiels","year":"1993","journal-title":"Transient neurological and ocular manifestations in primary thrombocythemia. Neurology."},{"key":"10.1016\/j.beha.2005.07.011_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.me.44.020193.001103","article-title":"Non-atheromatous arterial thrombosis","volume":"44","author":"Schafer","year":"1993","journal-title":"Annu Rew Med."},{"key":"10.1016\/j.beha.2005.07.011_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-8703(91)91019-J","article-title":"Thrombocythaemia and coronary artery disease","volume":"122","author":"Scheffer","year":"1991","journal-title":"Am Heart J."},{"key":"10.1016\/j.beha.2005.07.011_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archinte.139.6.695","article-title":"Polycythemia vera and mesenteric arterial thrombosis","volume":"139","author":"Myers","year":"1979","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.beha.2005.07.011_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bjo.53.4.279","article-title":"Migrating emboli of retinal arteries in thrombocythemia","volume":"53","author":"Singer","year":"1969","journal-title":"Br J Ophtalmol."},{"key":"10.1016\/j.beha.2005.07.011_bib16","first-page":"18","article-title":"Essential thrombocythemia: a rare case of central retinal artery occlusion","volume":"14","author":"Strassman","year":"1991","journal-title":"Metab Pediatr Syst Ophthalmol."},{"key":"10.1016\/j.beha.2005.07.011_bib17","first-page":"498","article-title":"Markiewicz","volume":"93","author":"Reisner","year":"1992","journal-title":"Tatarrsky I. Cardiac involvement in patients with myeloproliferative disorders. Am J Med."},{"key":"10.1016\/j.beha.2005.07.011_bib18","first-page":"285","article-title":"Dresch C & Rain JD","volume":"67","author":"Najean","year":"1987","journal-title":"Polycytemia vera in young people: an analysis of 58 cases diagnosed before 40 years. Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib19","first-page":"543","article-title":"Is polycythemia vera a serious disease in young adults?","volume":"86","author":"Perea","year":"2001","journal-title":"Haematologica."},{"key":"10.1016\/j.beha.2005.07.011_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denniger","year":"2000","journal-title":"Hepatology."},{"key":"10.1016\/j.beha.2005.07.011_bib21","first-page":"329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis","volume":"103","author":"Valla","year":"1985","journal-title":"A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med."},{"key":"10.1016\/j.beha.2005.07.011_bib22","doi-asserted-by":"crossref","unstructured":"Teofili L, De Stefano V, Leone G, Micalizzi P, et al. Hematological causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis. Thromb Haemost. 1992 Mar 2;67(3):297-301.","DOI":"10.1055\/s-0038-1648435"},{"key":"10.1016\/j.beha.2005.07.011_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2141.2002.03480.x","article-title":"The predictive value of clonogenic stem cell assays for the diagnosis of polycythemia vera","volume":"117","author":"Zwicky","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib24","first-page":"172","article-title":"Berk P & Wasserman L","volume":"23","author":"Tartaglia","year":"1986","journal-title":"Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib25","first-page":"265","article-title":"Cortelazzo S & Viero P","volume":"83","author":"Barbui","year":"1987","journal-title":"Aspirin and the risk of bleeding in patients with thrombocythemia. Am J Med."},{"key":"10.1016\/j.beha.2005.07.011_bib26","first-page":"101","article-title":"Jamin H & Schneider W","volume":"63","author":"Wehmeier","year":"1991","journal-title":"Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hemtol."},{"key":"10.1016\/j.beha.2005.07.011_bib27","doi-asserted-by":"crossref","unstructured":"Silverstein M & Minn R. Primary or hemorrhagic thrombocythemia. Arch Int Med. 1968;122:18-22.","DOI":"10.1001\/archinte.1968.00300060020004"},{"key":"10.1016\/j.beha.2005.07.011_bib28","first-page":"45","article-title":"Spontaneous deep hematomas in two patients with myelofibrosis","volume":"72","author":"Landolfi","year":"1987","journal-title":"Evidence of platelet membrane glycoprotein modifications. Haematologica."},{"key":"10.1016\/j.beha.2005.07.011_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.beha.2005.07.011_bib30","doi-asserted-by":"crossref","unstructured":"Marchioli R, Finazzi G, Landolfi R, Kutti J, et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol. 2005 Feb 14(Epub).","DOI":"10.1200\/JCO.2005.07.062"},{"key":"10.1016\/j.beha.2005.07.011_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.leu.2401270","article-title":"Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients","volume":"13","author":"Besses","year":"1999","journal-title":"Leukemia."},{"key":"10.1016\/j.beha.2005.07.011_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002770000244","article-title":"The predictive value of vascular risk factors and gender for the development of thrombotic complications in essentials thrombocythemia","volume":"80","author":"Jantunen","year":"2001","journal-title":"Ann Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.10153","article-title":"Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia","volume":"71","author":"Ruggeri","year":"2002","journal-title":"Am J Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib34","unstructured":"Afshar-Kharghan VLA, Gray L, Padilla A, Borthakur G, et al. Haemostatic gene polymorphisms and the prevalence of thrombohemorrhagic complications in polycythemia vera and essential thrombocythemia. Blood. 2001;98:471a."},{"key":"10.1016\/j.beha.2005.07.011_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.10254","article-title":"Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease","volume":"72","author":"Amitrano","year":"2003","journal-title":"Am J Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib36","unstructured":"Dicato MA, Schroell B & Berchem GJ. V Leiden mutations, prothrombin and methylene-tetrahydrofolate reductase are not risk factors for thromboembolic disease in essential thrombocythemia. Blood. 1999;94:11a\u00b0."},{"key":"10.1016\/j.beha.2005.07.011_bib37","doi-asserted-by":"crossref","first-page":"136140","DOI":"10.1002\/1096-8652(200010)65:2<136::AID-AJH8>3.0.CO;2-6","article-title":"High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders","volume":"65","author":"Faurschou","year":"2000","journal-title":"Am J Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib38","first-page":"551555","article-title":"Heis-Vahidi Fard N","volume":"105","author":"Gisslinger","year":"1999","journal-title":"Homocysteine levels in polycythaemia vera and essential thrombocythaemia. Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib39","first-page":"185191","article-title":"de Nully Brown P","volume":"69","author":"Jensen","year":"2002","journal-title":"Thorsen S & Hasselbalch HC. Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders. Am J Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib40","first-page":"802807","article-title":"Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis","volume":"87","author":"Harrison","year":"2002","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.beha.2005.07.011_bib41","first-page":"18271832","article-title":"Bertolini G & Barbui T","volume":"101","author":"Galli","year":"2003","journal-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib42","first-page":"73","article-title":"Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia","volume":"23","author":"Van Genderen","year":"1994","journal-title":"Presse Med."},{"key":"10.1016\/j.beha.2005.07.011_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"NEJM."},{"key":"10.1016\/j.beha.2005.07.011_bib44","unstructured":"Antithrombotic Trialist's Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002; 324:7186."},{"key":"10.1016\/j.beha.2005.07.011_bib45","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet."},{"key":"10.1016\/j.beha.2005.07.011_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1749-6632.1983.tb35199.x","article-title":"Platelet and red cell involvement in mural thrombogenesis","volume":"416","author":"Turitto","year":"1983","journal-title":"Ann NY Acad Sci."},{"key":"10.1016\/j.beha.2005.07.011_bib47","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.V80.8.1965.1965","article-title":"Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo","volume":"80","author":"Landolfi","year":"1992","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajh.2830200408","article-title":"The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases","volume":"20","author":"Buss","year":"1985","journal-title":"Am J Hematol."},{"key":"10.1016\/j.beha.2005.07.011_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/039139889301605s40","article-title":"Therapeutic thrombocytapheresis: a review of 132 patients","volume":"5","author":"Adami","year":"1993","journal-title":"Int J Artif Organs. ;16(suppl)"},{"key":"10.1016\/j.beha.2005.07.011_bib50","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortellazzo","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1016\/j.beha.2005.07.011_bib51","first-page":"82","article-title":"Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time","volume":"95","author":"Baker","year":"1988","journal-title":"Eur J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib52","first-page":"82","article-title":"Noris P & Piletta GC","volume":"95","author":"Balduini","year":"1991","journal-title":"Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders. Am J Clin Pathol."},{"key":"10.1016\/j.beha.2005.07.011_bib53","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0277-5379(83)90091-3","article-title":"Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function","volume":"19","author":"Barbui","year":"1983","journal-title":"Eur J Cancer Clini Oncol."},{"key":"10.1016\/j.beha.2005.07.011_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-88-1-7","article-title":"Platelet hyperaggregability and thrombosis in patients with thrombocythemia","volume":"88","author":"Wu","year":"1978","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.beha.2005.07.011_bib55","doi-asserted-by":"crossref","first-page":"191197","DOI":"10.1111\/j.1600-0609.1990.tb00456.x","article-title":"A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders","volume":"45","author":"Wehmeier","year":"1990","journal-title":"Eur J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib56","first-page":"12251230","article-title":"Increased thromboxane biosynthesis in essential thrombocythemia","volume":"74","author":"Rocca","year":"1995","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.beha.2005.07.011_bib57","first-page":"505509","article-title":"Platelet function in essential thrombocythemia","volume":"299","author":"Kaywin","year":"1978","journal-title":"Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med."},{"key":"10.1016\/j.beha.2005.07.011_bib58","first-page":"116124","article-title":"de Nully Brown P","volume":"110","author":"Jensen","year":"2000","journal-title":"Lund BV, Nielsen OJ & Hasselbalch HC. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders. Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib60","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib61","doi-asserted-by":"crossref","unstructured":"Budde U & Van Genderen PJ. Acquired von Willebrand disease in patients with high platelet counts. Semin Thromb Hemost. 1997;23:425-431.","DOI":"10.1055\/s-2007-996119"},{"key":"10.1016\/j.beha.2005.07.011_bib62","first-page":"42234234","article-title":"Robles R & Lamie B","volume":"87","author":"Furlan","year":"1996","journal-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature."},{"key":"10.1016\/j.beha.2005.07.011_bib64","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2141.1997.4823285.x","article-title":"Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count","volume":"99","author":"Van Genderen","year":"1997","journal-title":"Br J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib65","doi-asserted-by":"crossref","first-page":"42614266","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib66","first-page":"143151","article-title":"de Nully Brown P","volume":"66","author":"Jensen","year":"2001","journal-title":"Lund BV, Nielsen OJ & Hasselbalch HC. Increased circulating platelet\u2013leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol."},{"key":"10.1016\/j.beha.2005.07.011_bib67","doi-asserted-by":"crossref","first-page":"417424","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood."},{"key":"10.1016\/j.beha.2005.07.011_bib68","doi-asserted-by":"crossref","first-page":"670676","DOI":"10.1016\/S0301-472X(01)00640-3","article-title":"Clonal hemopoiesis and risk of thrombosis in young female patients with essential thrombocythemia","volume":"29","author":"Chiusolo","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beha.2005.07.011_bib69","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601","article-title":"Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia","volume":"100","author":"Shih","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.011_bib70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and someprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.07.011_bib71","first-page":"234","article-title":"Hirsh J &Roth G","volume":"126","author":"Patrono","year":"2004","journal-title":"Platelet-activ drugs: the relationship among dose, effectiveness and side effects: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest"},{"key":"10.1016\/j.beha.2005.07.011_bib72","doi-asserted-by":"crossref","unstructured":"Harrison CN, Campbell PJ, Buck G, Wheatley K et al. Hydroxyurea compared with anagrelide in high-risk essential thromboiythemia. N Engl J Med. 2005; 353: 33\u201345.","DOI":"10.1056\/NEJMoa043800"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260500099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260500099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T21:20:32Z","timestamp":1707081632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169260500099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S152169260500099X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.07.011","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}